MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea · Delayed Price · Currency is KRW 20,250
+450 (2.27%)
Apr 10, 2026, 3:30 PM KST
MEDIPOST Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 73,657 | 70,657 | 68,643 | 64,201 | 54,856 |
Other Revenue | - | - | -0 | - | - |
| 73,657 | 70,657 | 68,643 | 64,201 | 54,856 | |
Revenue Growth (YoY) | 4.25% | 2.93% | 6.92% | 17.03% | 12.81% |
Cost of Revenue | 28,220 | 26,519 | 28,459 | 25,828 | 22,994 |
Gross Profit | 45,436 | 44,138 | 40,184 | 38,373 | 31,863 |
Selling, General & Admin | 40,137 | 36,028 | 33,699 | 35,283 | 23,357 |
Research & Development | 71,309 | 54,636 | 29,216 | 19,004 | 11,703 |
Amortization of Goodwill & Intangibles | 246.32 | 574.23 | 473.25 | 466.2 | 431.35 |
Other Operating Expenses | 766.51 | 802.57 | 659.19 | 601.16 | 508.38 |
Operating Expenses | 113,460 | 92,690 | 65,447 | 55,807 | 37,587 |
Operating Income | -68,023 | -48,552 | -25,263 | -17,434 | -5,724 |
Interest Expense | -533.2 | -499.28 | -6,389 | -8,276 | -3,556 |
Interest & Investment Income | 2,130 | 3,400 | 2,535 | 1,448 | 1,225 |
Earnings From Equity Investments | -3,818 | -11,092 | -4,023 | -15,081 | 205.04 |
Currency Exchange Gain (Loss) | 132.89 | 1,733 | 132.16 | 1,019 | 16.15 |
Other Non Operating Income (Expenses) | -23,056 | -18,328 | 31,881 | 32,531 | 3,693 |
EBT Excluding Unusual Items | -93,169 | -73,339 | -1,127 | -5,794 | -4,141 |
Gain (Loss) on Sale of Investments | 8,824 | 10,774 | 5,596 | 12,283 | 6,193 |
Gain (Loss) on Sale of Assets | 10.31 | -3.89 | -54.29 | -0.82 | -26.25 |
Asset Writedown | -1,539 | -363.3 | - | - | -1,426 |
Other Unusual Items | - | - | - | 19.88 | 1.66 |
Pretax Income | -85,873 | -62,931 | 4,414 | 6,508 | 602.44 |
Income Tax Expense | 118.57 | 446.1 | -536.6 | 4,403 | 1,569 |
Earnings From Continuing Operations | -85,991 | -63,377 | 4,951 | 2,106 | -966.42 |
Minority Interest in Earnings | 593.46 | 852.51 | 889.38 | 963.03 | 283.16 |
Net Income | -85,398 | -62,525 | 5,840 | 3,069 | -683.26 |
Net Income to Common | -85,398 | -62,525 | 5,840 | 3,069 | -683.26 |
Net Income Growth | - | - | 90.31% | - | - |
Shares Outstanding (Basic) | 35 | 34 | 20 | 16 | 16 |
Shares Outstanding (Diluted) | 35 | 34 | 25 | 19 | 16 |
Shares Change (YoY) | 4.03% | 34.70% | 36.23% | 15.67% | 3.63% |
EPS (Basic) | -2408.00 | -1834.00 | 287.36 | 190.06 | -42.54 |
EPS (Diluted) | -2408.00 | -1834.00 | 231.00 | 165.00 | -43.00 |
EPS Growth | - | - | 40.00% | - | - |
Free Cash Flow | -60,061 | -39,932 | -21,638 | -8,577 | -6,119 |
Free Cash Flow Per Share | -1693.56 | -1171.30 | -854.93 | -461.66 | -380.96 |
Gross Margin | 61.69% | 62.47% | 58.54% | 59.77% | 58.08% |
Operating Margin | -92.35% | -68.72% | -36.80% | -27.16% | -10.44% |
Profit Margin | -115.94% | -88.49% | 8.51% | 4.78% | -1.25% |
Free Cash Flow Margin | -81.54% | -56.52% | -31.52% | -13.36% | -11.15% |
EBITDA | -62,037 | -42,530 | -19,392 | -12,052 | -826.06 |
EBITDA Margin | -84.22% | -60.19% | -28.25% | -18.77% | -1.51% |
D&A For EBITDA | 5,986 | 6,022 | 5,872 | 5,382 | 4,898 |
EBIT | -68,023 | -48,552 | -25,263 | -17,434 | -5,724 |
EBIT Margin | -92.35% | -68.72% | -36.80% | -27.16% | -10.44% |
Effective Tax Rate | - | - | - | 67.65% | 260.42% |
Advertising Expenses | 2,397 | 1,987 | 1,856 | 1,843 | 1,446 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.